Other

Unrealized Gain (Loss) on Securities

Kailera Therapeutics Unrealized Gain (Loss) on Securities decreased by 12583.3% to -$761.00K in Q1 2026 compared to the prior quarter.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
Metric ID: cop_unrealized_gain_loss_on_securities

Historical Data

2 periods
 Q1 '25Q1 '26
Value-$6.00K-$761.00K
QoQ Change—<-999%
YoY Change—<-999%
Range-$761.00K – -$6.00K
Avg YoY Growth<-999%
Median YoY Growth<-999%

Frequently Asked Questions

What is Kailera Therapeutics 's unrealized gain (loss) on securities?
Kailera Therapeutics (KLRA) reported unrealized gain (loss) on securities of -$761.00K in Q1 2026.